Your browser does not support JavaScript!
SAINT-GOBAINTour Saint-Gobain12 place de l'Iris92400 CourbevoieFRANCE
Follow the video replay from the Presentation of the Saint-Gobain Full-Year 2020 Results (from February 26th at 8:30 AM CET)
Saint-Gobain Life Sciences is broadening its medical components capabilities with the acquisition of MS Techniques and Transluminal.
First-half 2020 results
Laurence Pernot is Vice President of Communications for Saint-Gobain Group. Given that the COVID-19 crisis has dealt us a new hand, she explains how brands can – and must – start building the post-crisis world.
At Saint-Gobain, the health of our employees and our customers is our top priority. We have put in place protective measures in order to continue to meet the essential expectations of our customers and partners, in strict compliance with local and national rules and directives. At its level, the Group strives to play its role as a corporate citizen to protect the health of all and limit the spread of the virus.
Sharp 50.2% rise in free cash flow
Recurring earnings per share up 11.0%
Increase in operating margin of 30 basis points
